REQUEST A DEMO
Total
USD $0.00
Search more companies

Bionet Corp. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bionet Corp. Profile Updated: February 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Biotechnology was established in 2000.The technology was first introduced in 1999 from the University of Minnesota and PugetSound Blood Center about the operation specifications of the cord blood bank. In 2002 it joined the United States AABB and obtained AABB certification. In 2003 it went public. In 2007 it went listed. In 2006 it covered the purchasing and storage services of hematopoietic stem cells, the purchasing and storage services of mesenchymal stem cells (MSC), genetic testing (SMA) and biomedical beauty. Biotechnology belongs to both the upstream collectors of raw materials and the middle stream explorers of the raw materials and technology suppliers. It cooperated with the downstream users (End User) or co-producers of the final product.

Headquarters
1F,No.28, Ln. 36, Xinhu 1St Rd
Taipei City; Taipei City;

Contact Details: Purchase the Bionet Corp. report to view the information.

Website: http://www.babybanks.com

Basic Information
Total Employees:
Purchase the Bionet Corp. report to view the information.
Outstanding Shares:
Purchase the Bionet Corp. report to view the information.
Financial Auditors:
Purchase the Bionet Corp. report to view the information.
Incorporation Date:
August 17, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
4.52%
Purchase this report to view the information.
3.29%
Purchase this report to view the information.
2.28%
Purchase this report to view the information.
2%
Purchase this report to view the information.
Subsidiaries
Crown Star Alliance Limited (Crown Star)
100%
Company Performance
Financial values in the chart are available after Bionet Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
14.99%
Total operating revenue
15.56%
Operating profit (EBIT)
66.25%
EBITDA
15.38%
Net Profit (Loss) for the Period
51.89%
Total assets
27.73%
Total equity
30%
Operating Profit Margin (ROS)
2.58%
Net Profit Margin
1.75%
Return on Equity (ROE)
0.68%
Quick Ratio
1.17%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?